Literature DB >> 18784657

Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms.

Robert J DeRubeis1, Greg J Siegle, Steven D Hollon.   

Abstract

Depression is one of the most prevalent and debilitating of the psychiatric disorders. Studies have shown that cognitive therapy is as efficacious as antidepressant medication at treating depression, and it seems to reduce the risk of relapse even after its discontinuation. Cognitive therapy and antidepressant medication probably engage some similar neural mechanisms, as well as mechanisms that are distinctive to each. A precise specification of these mechanisms might one day be used to guide treatment selection and improve outcomes.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18784657      PMCID： PMC2748674          DOI： 10.1038/nrn2345

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN： 1471-003X            Impact factor:   34.870


  99 in total

1.  Cognitive therapy and pharmacotherapy for depression. Singly and in combination.

Authors:  S D Hollon; R J DeRubeis; M D Evans; M J Wiemer; M J Garvey; W M Grove; V B Tuason
Journal:  Arch Gen Psychiatry       Date:  1992-10

2.  Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings.

Authors:  A L Brody; S Saxena; P Stoessel; L A Gillies; L A Fairbanks; S Alborzian; M E Phelps; S C Huang; H M Wu; M L Ho; M K Ho; S C Au; K Maidment; L R Baxter
Journal:  Arch Gen Psychiatry       Date:  2001-07

3.  Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression.

Authors:  Mario Liotti; Helen S Mayberg; Scott McGinnis; Stephen L Brannan; Paul Jerabek
Journal:  Am J Psychiatry       Date:  2002-11       Impact factor: 18.112

4.  Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals.

Authors:  Greg J Siegle; Stuart R Steinhauer; Michael E Thase; V Andrew Stenger; Cameron S Carter
Journal:  Biol Psychiatry       Date:  2002-05-01       Impact factor: 13.382

5.  Pathways for emotion: interactions of prefrontal and anterior temporal pathways in the amygdala of the rhesus monkey.

Authors:  H T Ghashghaei; H Barbas
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

6.  Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness.

Authors:  H S Mayberg; M Liotti; S K Brannan; S McGinnis; R K Mahurin; P A Jerabek; J A Silva; J L Tekell; C C Martin; J L Lancaster; P T Fox
Journal:  Am J Psychiatry       Date:  1999-05       Impact factor: 18.112

7.  Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features.

Authors:  Greg J Siegle; Wesley Thompson; Cameron S Carter; Stuart R Steinhauer; Michael E Thase
Journal:  Biol Psychiatry       Date:  2006-10-06       Impact factor: 13.382

8.  Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study.

Authors:  Amit Anand; Yu Li; Yang Wang; Jingwei Wu; Sujuan Gao; Lubna Bukhari; Vincent P Mathews; Andrew Kalnin; Mark J Lowe
Journal:  Neuropsychopharmacology       Date:  2005-07       Impact factor: 7.853

9.  Limbic-frontal circuitry in major depression: a path modeling metanalysis.

Authors:  D A Seminowicz; H S Mayberg; A R McIntosh; K Goldapple; S Kennedy; Z Segal; S Rafi-Tari
Journal:  Neuroimage       Date:  2004-05       Impact factor: 6.556

10.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272
View more
  185 in total

1.  [Neuroimaging markers: their role for differential diagnosis and therapeutic decisions in personalized psychiatry].

Authors:  O Gruber
Journal:  Nervenarzt       Date:  2011-11       Impact factor: 1.214

2.  Will there be a role for neuroimaging in clinical psychiatry?

Authors:  Glenda M Macqueen
Journal:  J Psychiatry Neurosci       Date:  2010-09       Impact factor: 6.186

Review 3.  The modification of attentional bias to emotional information: A review of the techniques, mechanisms, and relevance to emotional disorders.

Authors:  Michael Browning; Emily A Holmes; Catherine J Harmer
Journal:  Cogn Affect Behav Neurosci       Date:  2010-03       Impact factor: 3.282

4.  Stress across the life course and depression in a rapidly developing population: the Guangzhou Biobank Cohort Study.

Authors:  Michael Y Ni; Chaoqiang Jiang; Kar Keung Cheng; Weisen Zhang; Stephen E Gilman; Tai Hing Lam; Gabriel M Leung; C Mary Schooling
Journal:  Int J Geriatr Psychiatry       Date:  2015-10-09       Impact factor: 3.485

5.  PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder-study design and methodology of a multicenter double-blind randomized placebo-controlled trial.

Authors:  Malek Bajbouj; Sabine Aust; Jan Spies; Ana-Lucia Herrera-Melendez; Sarah V Mayer; Maike Peters; Christian Plewnia; Andreas J Fallgatter; Lukas Frase; Claus Normann; Nora Behler; Linda Wulf; Eva-Lotta Brakemeier; Frank Padberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-12-06       Impact factor: 5.270

Review 6.  Neuroimaging for psychotherapy research: current trends.

Authors:  Carol P Weingarten; Timothy J Strauman
Journal:  Psychother Res       Date:  2014-02-17

7.  Mental illness and well-being: an affect regulation perspective.

Authors:  James J Gross; Helen Uusberg; Andero Uusberg
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

8.  The Effect of a Physical Training with the Use of an Exoskeleton on Depression Levels in Institutionalized Elderly Patients: A Pilot Study.

Authors:  W Verrusio; A Renzi; F Cecchetti; F Gaj; M Coi; M Ripani; M Cacciafesta
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

9.  COGNITION-CHILDHOOD MALTREATMENT INTERACTIONS IN THE PREDICTION OF ANTIDEPRESSANT OUTCOMES IN MAJOR DEPRESSIVE DISORDER PATIENTS: RESULTS FROM THE iSPOT-D TRIAL.

Authors:  Shefali Miller; Lisa M McTeague; Anett Gyurak; Brian Patenaude; Leanne M Williams; Stuart M Grieve; Mayuresh S Korgaonkar; Amit Etkin
Journal:  Depress Anxiety       Date:  2015-04-27       Impact factor: 6.505

Review 10.  Screening for common mental disorders in low resource settings: reasons for caution and a way forward.

Authors:  Ashraf Kagee; Alexander C Tsai; Crick Lund; Mark Tomlinson
Journal:  Int Health       Date:  2013-03       Impact factor: 2.473
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.